Survey of clinical practice pattern in Germany’s certified chest pain units: Adherence to the European Society of Cardiology guidelines on non-ST-segment elevation acute coronary syndrome; [Versorgungsanalyse unter den deutschen zertifizierten Chest Pain Units: Klinische Umsetzung der Leitlinien der Europäischen Gesellschaft für Kardiologie zum akuten Koronarsyndrom ohne ST-Strecken-Hebung]

被引:0
|
作者
Breuckmann F. [1 ]
Settelmeier S. [1 ]
Rassaf T. [1 ]
Post F. [2 ]
Haerer W. [3 ]
Bauersachs J. [4 ]
Mudra H. [5 ]
Voigtländer T. [6 ]
Senges J. [7 ]
Münzel T. [8 ]
Giannitsis E. [9 ]
机构
[1] Department of Cardiology and Vascular Medicine, West German Heart and Vascular Center Essen, University Duisburg-Essen, Essen
[2] Department of Cardiology, Katholisches Klinikum Koblenz-Montabaur, Koblenz
[3] Heart Clinic Ulm, Ulm
[4] Department of Cardiology and Angiology, Hannover Medical School, Hannover
[5] Heart and Vascular Center Munich Maffeistraße and Nymphenburg (Klinikum 3. Orden), Munich
[6] CCB, Cardioangiologisches Centrum Bethanien, Frankfurt am Main
[7] Institute for Myocardial Infarction Research Foundation, Ludwigshafen
[8] Department of Cardiology, University Medical Center Mainz, Johannes Gutenberg-University Mainz, Mainz
[9] Department of Medicine III, University Hospital Heidelberg, Heidelberg
关键词
Antiplatelet therapy; PCI; Standard of care; Timing; Troponin protocol;
D O I
10.1007/s00059-021-05079-2
中图分类号
学科分类号
摘要
Background: We aimed to analyze the 2020 standard of care in certified German chest pain units (CPU) with a special focus on non-ST-segment elevation acute coronary syndrome (NSTE-ACS) through a voluntary survey obtained from all certified units, using a prespecified questionnaire. Methods: The assessment included the collection of information on diagnostic protocols, risk assessment, management and treatment strategies in suspected NSTE-ACS, the timing of invasive therapy in non-ST-segment elevation myocardial infarction (NSTEMI), and the choice of antiplatelet therapy. Results: The response rate was 75%. Among all CPUs, 77% are currently using the European Society of Cardiology (ESC) 0/3‑h high-sensitive troponin protocol, and only 20% use the ESC 0/1‑h high-sensitive troponin protocol as a default strategy. Conventional ergometry is still the commonly performed stress test with a utilization rate of 47%. Among NSTEMI patients, coronary angiography is planned within 24 h in 96% of all CPUs, irrespective of the day of the week. Prasugrel is the P2Y12 inhibitor of choice in ST-segment elevation myocardial infarction (STEMI), but despite the impact of the ISAR-REACT 5 trial on selection of antiplatelet therapy, ticagrelor is still favored over prasugrel in NSTE-ACS. If triple therapy is used in NSTE-ACS with atrial fibrillation, it is maintained up to 4 weeks in 51% of these patients. Conclusion: This survey provides evidence that Germany’s certified CPUs ensure a high level of guideline adherence and quality of care. The survey also identified areas in need of improvement such as the high utilization rate of stress electrocardiogram (ECG). © 2021, The Author(s).
引用
收藏
页码:543 / 552
页数:9
相关论文
共 6 条